Stay updated on Pembrolizumab for Intermediate Risk NMIBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Intermediate Risk NMIBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Intermediate Risk NMIBC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page’s footer/version label was updated to “Revision: v3.5.3,” and a related-topics section entry referencing “Bladder cancer” and “MedlinePlus Genetics” was removed.
    Difference
    0.2%
    Check dated 2026-04-25T18:44:24.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Added 'Bladder cancer' and related topics including MedlinePlus Genetics, and updated the page revision from v3.5.0 to v3.5.2.
    Difference
    0.2%
    Check dated 2026-04-18T13:40:21.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2026-04-11T10:53:00.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Added 'Bladder cancer' as a related topic and added 'MedlinePlus Genetics' as a related topic.
    Difference
    0.2%
    Check dated 2026-04-04T06:19:00.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added and the previous Revision: v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-21T01:07:21.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Removed the 'Bladder cancer' topic and the 'MedlinePlus Genetics' related topics from the page.
    Difference
    0.2%
    Check dated 2026-03-13T22:36:13.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Intermediate Risk NMIBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Intermediate Risk NMIBC Clinical Trial page.